This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2024 Feb;309(2):729.

doi: 10.1007/s00404-023-07330-z.

Retraction Note: A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptin in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level

Mohammad Ebrahim Parsanezhad^{1

2}, Saeed Alborzi³, Bahia Namavar Jahromi³

Affiliations

Affiliations

¹ Department of Obstetrics and Gynecology, Medical School, Shiraz University of Medical Sciences, Shiraz, Iran. parsame@sums.ac.ir.
² , Parsanezhad Jenaer Str 41, 28215, Bremen, Germany. parsame@sums.ac.ir.
³ Department of Obstetrics and Gynecology, Medical School, Shiraz University of Medical Sciences, Shiraz, Iran.

PMID: 38142249
DOI: 10.1007/s00404-023-07330-z

Retraction Note: A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptin in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level

Mohammad Ebrahim Parsanezhad et al. Arch Gynecol Obstet. 2024 Feb.

. 2024 Feb;309(2):729.

doi: 10.1007/s00404-023-07330-z.

Authors

Mohammad Ebrahim Parsanezhad^{1

2}, Saeed Alborzi³, Bahia Namavar Jahromi³

Affiliations

¹ Department of Obstetrics and Gynecology, Medical School, Shiraz University of Medical Sciences, Shiraz, Iran. parsame@sums.ac.ir.
² , Parsanezhad Jenaer Str 41, 28215, Bremen, Germany. parsame@sums.ac.ir.
³ Department of Obstetrics and Gynecology, Medical School, Shiraz University of Medical Sciences, Shiraz, Iran.

PMID: 38142249
DOI: 10.1007/s00404-023-07330-z

No abstract available

PubMed Disclaimer

Retraction of

A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptin in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level.
Parsanezhad ME, Alborzi S, Namavar Jahromi B. Parsanezhad ME, et al. Arch Gynecol Obstet. 2004 Jan;269(2):125-9. doi: 10.1007/s00404-002-0437-x. Epub 2002 Oct 24. Arch Gynecol Obstet. 2004. Retraction in: Arch Gynecol Obstet. 2024 Feb;309(2):729. doi: 10.1007/s00404-023-07330-z. PMID: 14648180 Retracted. Clinical Trial.

References

Reference

1. Parsanezhad ME, Alborzi S, Jahromi BN (2002) A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptine in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level. Int J Fertil Womens Med 47(6):272–277 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Springer